Abbott (ABT) acquires Cardiovascular Systems (CSII) in 'brilliant move'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Cardiovascular Systems (CSII) PT Raised to $20 at Stifel
February 9, 2023 8:07 AM ESTStifel analyst Mathew Blackman raised the price target on Cardiovascular Systems (NASDAQ: CSII) to $20.00 (from $18.00) while maintaining a Hold rating.... More
Lake Street Capital Markets Downgrades Cardiovascular Systems (CSII) to Sell
February 9, 2023 7:43 AM ESTLake Street Capital Markets analyst Brooks O'neil downgraded Cardiovascular Systems (NASDAQ: CSII) from Hold to Sell.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $13.31 yesterday.
... MoreAbbott (ABT) to acquire Cardiovascular Systems (CSII) for $20/share
February 9, 2023 6:22 AM ESTAbbott (NYSE: ABT) and Cardiovascular Systems, Inc. (NASDAQ: CSII), today announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million.
CSI is a leader in devices for... More
Cardiovascular Systems (CSII) Misses Q2 EPS by 5c
February 9, 2023 4:50 AM ESTCardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.20), $0.05 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $61.5 million versus the consensus estimate of $63.06 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
... More